Literature DB >> 21851489

Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents.

A H Diacon1, J S Maritz, A Venter, P D van Helden, R Dawson, P R Donald.   

Abstract

The measurement of early bactericidal activity (EBA) is the first step in the clinical investigation of antituberculosis agents. EBA is determined by quantifying the viable sputum mycobacterial load on consecutive days of treatment. To investigate whether time to positivity (TTP) in mycobacterial liquid culture can substitute for colony forming unit (CFU) counting on agar plates we compared the error variation of TTP and CFU in 2115 pooled sputum samples collected overnight from 250 individuals included in five EBA studies. We found that the technical variation between duplicate laboratory measurements and the within-subject or day-to-day variation were similar for TTP (8.5% and 27.4% of total variation, respectively) and CFU (6.7% and 29.3% of total variation). The ability of the measurements to separate the EBA of 22 treatment arms was determined with group rank correlation of means and one-way analysis of variance. Except for the EBA over 0-2 days, individual and group EBAs measured with TTP and CFU were highly correlated. Treatment group means rank correlation coefficients were r=0.472, r=0.910 and r=0.818, respectively, for EBA 0-2 days, EBA 0-7 days and EBA 0-14 days. Analysis of variance significantly favoured TTP over CFU for discrimination between groups with F values of 6.58 and 1.87, 7.77 and 4.58, and 8.71 and 3.56, respectively. We conclude that TTP is an acceptable alternative to CFU counting for the determination of the viable sputum mycobacterial load in EBA studies of up to 14 days duration.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21851489     DOI: 10.1111/j.1469-0691.2011.03626.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

1.  Sputum volume predicts sputum mycobacterial load during the first 2 weeks of antituberculosis treatment.

Authors:  Miriam N Karinja; Tonya M Esterhuizen; Sven O Friedrich; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2014-12-31       Impact factor: 5.948

2.  Short-term storage does not affect the quantitative yield of Mycobacterium tuberculosis in sputum in early-bactericidal-activity studies.

Authors:  Eva Kolwijck; Melissa Mitchell; Amour Venter; Sven O Friedrich; Rod Dawson; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

3.  Phase II dose-ranging trial of the early bactericidal activity of PA-824.

Authors:  Andreas H Diacon; Rodney Dawson; Jeannine du Bois; Kim Narunsky; Amour Venter; Peter R Donald; Christo van Niekerk; Ngozi Erondu; Ann M Ginsberg; Piet Becker; Melvin K Spigelman
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.

Authors:  Michael A Lyons
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

5.  Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.

Authors:  Robin J Svensson; Wilber Sabiiti; Gibson S Kibiki; Nyanda E Ntinginya; Nilesh Bhatt; Geraint Davies; Stephen H Gillespie; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

6.  Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity.

Authors:  Xavier A Kayigire; Sven O Friedrich; Amour Venter; Rodney Dawson; Stephen H Gillespie; Martin J Boeree; Norbert Heinrich; Michael Hoelscher; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

7.  A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.

Authors:  Emmanuel Chigutsa; Kashyap Patel; Paolo Denti; Marianne Visser; Gary Maartens; Carl M J Kirkpatrick; Helen McIlleron; Mats O Karlsson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

8.  The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment.

Authors:  Isobella Honeyborne; Bariki Mtafya; Patrick P J Phillips; Michael Hoelscher; Elias N Ntinginya; Anke Kohlenberg; Andrea Rachow; Gabriel Rojas-Ponce; Timothy D McHugh; Norbert Heinrich
Journal:  J Clin Microbiol       Date:  2014-05-28       Impact factor: 5.948

9.  Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.

Authors:  Edith E Machowski; Matebogo Letutu; Limakatso Lebina; Ziyaad Waja; Reginah Msandiwa; Minja Milovanovic; Bhavna G Gordhan; Kennedy Otwombe; Sven O Friedrich; Richard Chaisson; Andreas H Diacon; Bavesh Kana; Neil Martinson
Journal:  BMC Infect Dis       Date:  2021-05-22       Impact factor: 3.090

10.  Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB.

Authors:  David A Barr; Mercy Kamdolozi; Yo Nishihara; Victor Ndhlovu; Margaret Khonga; Geraint R Davies; Derek J Sloan
Journal:  Tuberculosis (Edinb)       Date:  2016-03-23       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.